Allocetra
Asset
Apoptotic donor cells promote macrophage reprogramming to resolve inflammation and restore immune homeostasis.
- Stage
- Phase 2
- Modality
- Cell therapy
- Target
- Inflammation
- 1
- Indication
- 1
- Trial
- 1
- Developer
Indications
1Primary knee osteoarthritis
Phase 2, Recruiting, NCT07580716, clinicaltrials.gov, 15 Oct 2026
In the full profile
- Targets and what it contains1
- Owner and partners1
- Trials1
- Evidence for its targets1
- Aging relevance1
- Signals2
Every asset’s record: target, stage, trials and the evidence behind it.